Skip to main content

Peer Review reports

From: Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

Original Submission
22 Jul 2019 Submitted Original manuscript
10 Aug 2019 Author responded Author comments - Kejun Liu
Resubmission - Version 2
10 Aug 2019 Submitted Manuscript version 2
4 Sep 2019 Reviewed Reviewer Report - Tetsuhiko Asao
15 Sep 2019 Reviewed Reviewer Report - Samik Chakraborty
14 Nov 2019 Author responded Author comments - Kejun Liu
Resubmission - Version 3
14 Nov 2019 Submitted Manuscript version 3
25 Nov 2019 Reviewed Reviewer Report - Samik Chakraborty
4 Dec 2019 Reviewed Reviewer Report - Tetsuhiko Asao
27 Dec 2019 Author responded Author comments - Kejun Liu
Resubmission - Version 4
27 Dec 2019 Submitted Manuscript version 4
3 Jan 2020 Reviewed Reviewer Report - Tetsuhiko Asao
11 Jan 2020 Author responded Author comments - Kejun Liu
Resubmission - Version 5
11 Jan 2020 Submitted Manuscript version 5
Publishing
14 Jan 2020 Editorially accepted
30 Jan 2020 Article published 10.1186/s12885-020-6543-y

You can find further information about peer review here.

Back to article page